Pfizer director acquires 1,613 deferred stock units
The units are deferred director compensation, settled in cash or common stock at the director’s election following retirement from the Board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pfizer Inc director Joseph Echevarria acquired 1,613.185 Phantom Stock Units on September 25, 2026. The reported price was $28.67 per unit, and his reported balance after the acquisition was 169,739.319 units.
Each unit represents one phantom share of common stock. The units represent deferred director compensation, including dividend equivalents, and are settled in cash or common stock at the director’s election following his retirement from the Board of Directors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units F1, F2 | 1,613.185 | $28.67 | $46K |
Footnotes (2)
- F1. Each unit represents one phantom share of common stock.
- F2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Key Figures
Key Terms
Phantom Stock Units financial
deferred director's compensation financial
dividend equivalents financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many PFE Phantom Stock Units did Joseph Echevarria acquire?
How are PFE Phantom Stock Units settled?
AI-generated analysis. How Rhea-AI works. Not financial advice.